Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial
Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a minor metadata update to the page. This does not reflect a change in core content or functionality.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a site/build metadata change rather than an alteration to the clinical trial content.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3 label.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.1%

- Check103 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1; this is a minor site maintenance update that does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.